Medical Proteomics Unit, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, 6thFloor - SiMR Building, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand.
J Transl Med. 2023 Nov 28;21(1):862. doi: 10.1186/s12967-023-04750-y.
Defects and deficiency of AT-rich interactive domain-containing protein 1A (ARID1A) encoded by a tumor suppressor gene ARID1A have recently been suggested to get involved in angiogenesis, a crucial process in carcinogenesis. However, molecular mechanisms of ARID1A deficiency to induce angiogenesis in kidney cancer remain underinvestigated.
We performed large-scale identification of ARID1A protein interactors in renal tubular epithelial cells (RTECs) using immunoprecipitation (IP) followed by nanoLC-ESI-LTQ-Orbitrap tandem mass spectrometry (MS/MS). Their roles in angiogenesis were investigated using various assays.
A total of 74 ARID1A-interacting proteins were identified. Protein-protein interactions analysis revealed that these identified proteins interacted directly or indirectly with ARID1A. Among them, the direct interaction between ARID1A and β-actin was validated by IP and reciprocal IP followed by Western blotting. Small interfering RNA (siRNA) was used for single and double knockdowns of ARID1A and ACTB. Semi-quantitative RT-PCR demonstrated that deficiency of ARID1A, but not ACTB, significantly affected expression of angiogenesis-related genes in RTECs (VEGF and FGF2 were increased, whereas PDGF and EGF were decreased). However, the knockdowns did not affect TGFB1 and FGF1 levels. The quantitative mRNA expression data of VEGF and TGFB1 were consistent with the secreted levels of their protein products as measured by ELISA. Only secreted products derived from ARID1A-deficient RTECs significantly increased endothelial cells (ECs) migration and tube formation. Some of the other carcinogenic features could also be confirmed in the ARID1A-deficient RTECs, including increased cell migration and chemoresistance. Double knockdowns of both ARID1A and ACTB did not enhance the effects of single ARID1A knockdown in all assays.
We report herein a large dataset of the ARID1A-interacting proteins in RTECs using an IP-MS/MS approach and confirm the direct interaction between ARID1A and β-actin. However, the role of ARID1A deficiency in angiogenesis is independent of β-actin.
肿瘤抑制基因 ARID1A 编码的富含 AT 的相互作用结构域蛋白 1A(ARID1A)的缺陷和缺失最近被认为参与了血管生成,这是癌症发生过程中的一个关键过程。然而,ARID1A 缺乏诱导肾癌血管生成的分子机制仍未得到充分研究。
我们使用免疫沉淀(IP) followed by nanoLC-ESI-LTQ-Orbitrap tandem mass spectrometry(MS/MS)对肾小管上皮细胞(RTECs)中的 ARID1A 蛋白相互作用物进行了大规模鉴定。使用各种测定方法研究了它们在血管生成中的作用。
共鉴定出 74 种 ARID1A 相互作用蛋白。蛋白质-蛋白质相互作用分析表明,这些鉴定出的蛋白质与 ARID1A 直接或间接相互作用。其中,通过 IP 和相互 IP followed by Western blotting 验证了 ARID1A 与β-肌动蛋白之间的直接相互作用。使用小干扰 RNA(siRNA)对 ARID1A 和 ACTB 进行单和双敲低。半定量 RT-PCR 表明,ARID1A 的缺失,而不是 ACTB 的缺失,显著影响了 RTECs 中血管生成相关基因的表达(VEGF 和 FGF2 增加,而 PDGF 和 EGF 减少)。然而,敲低并不影响 TGFB1 和 FGF1 的水平。VEGF 和 TGFB1 的定量 mRNA 表达数据与 ELISA 测量的其蛋白产物的分泌水平一致。只有来自 ARID1A 缺陷 RTECs 的分泌产物显著增加了内皮细胞(ECs)的迁移和管状形成。在 ARID1A 缺陷的 RTECs 中也可以确认一些其他的致癌特征,包括细胞迁移和化疗耐药性的增加。在所有测定中,对 ARID1A 和 ACTB 进行双重敲低并没有增强单独对 ARID1A 进行敲低的效果。
本文通过 IP-MS/MS 方法报道了 RTECs 中 ARID1A 相互作用蛋白的大型数据集,并证实了 ARID1A 与 β-肌动蛋白之间的直接相互作用。然而,ARID1A 缺乏在血管生成中的作用独立于 β-肌动蛋白。